Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

New guidance details Medicare drug price negotiations coming in 2026

For the first time, Medicare will have the ability to negotiate prices of certain medications. These negotiations will focus on key questions such as the drug's benefits, the extent to which it fulfills an unmet medical need and its impact on Medicare beneficiaries.

Industry groups agree MedPAC’s inflationary update is not enough

The Medicare Payment Advisory Commission (MedPAC) wants to tie physician payments to inflation. Healthcare groups say it doesn't go far enough

Thumbnail

Most US adults with medical debt owe hospitals

A significant portion of U.S. adults have some past-due medical debt, according to a recent study from the Urban Institute, and the majority of those with debt owe non-profit hospitals.

pain pills opioids

DOJ sues Rite Aid over role in opioid epidemic

According to the complaint, Rite Aid allegedly filled “at least” hundreds of thousands of unlawful prescriptions for controlled substances that lacked legitimate medical purpose, were not for a medically accepted indication or were not issued in the usual course of professional practice.

VA first to cover new ALZ drug

A new Alzheimer’s disease drug, Leqembi (lecanemab), will be covered by the Veterans Affairs for some patients, making the VA the first insurer to cover the drug.

Thumbnail

Pfizer to acquire Seagen for $43B

“Together, Pfizer and Seagen seek to accelerate the next generation of cancer breakthroughs and bring new solutions to patients by combining the power of Seagen’s antibody-drug conjugate technology with the scale and strength of Pfizer’s capabilities and expertise," says Pfizer Chairman and CEO Albert Bourla, PhD.

Thumbnail

Former CEO indicted for fake medical device implanted in patients

Laura Perryman, the former chief of Florida-based Stimwave, allegedly created a non-functioning “dummy device” that was used to treat patients suffering from chronic pain.

Oversight Committee launches investigation into pharmacy benefit managers

CVS Caremark, Express Scripts and OptumRx have been asked to provide documents, communications and information related to their practices.

Around the web

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Cardiologists and other physicians may soon need to provide much more information when ordering remote patient monitoring for Medicare patients.

Why are so many cardiovascular devices involved in Class I recalls? One possible reason could be the large number of devices hitting the market without undergoing much premarket clinical testing. 

Trimed Popup
Trimed Popup